Načítá se...
Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer
Anthracyclines are among the most effective chemotherapeutics ever developed, but they produce grueling side effects and serious adverse events, and resistance often develops over time. We found that these compounds can be sequestered by secreted cellular prion protein (PrP(C)), which blocks their c...
Uloženo v:
| Vydáno v: | JCI Insight |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Clinical Investigation
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483007/ https://ncbi.nlm.nih.gov/pubmed/30830863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.124092 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|